investorscraft@gmail.com

Intrinsic ValueNihon Nohyaku Co., Ltd. (4997.T)

Previous Close¥1,014.00
Intrinsic Value
Upside potential
Previous Close
¥1,014.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Nihon Nohyaku Co., Ltd. is a specialized agrochemical company with a diversified portfolio spanning fungicides, insecticides, herbicides, and niche chemical applications for home gardening, termite control, and animal health. Operating primarily in Japan but with an international presence, the company leverages its nearly century-old expertise to serve agricultural and pharmaceutical markets. Its subsidiary relationship with Adeka Corporation provides strategic stability, while its focus on R&D ensures competitive product differentiation in the agricultural inputs sector. The company’s dual emphasis on crop protection and animal health products positions it as a mid-tier player in a market dominated by global giants, yet it maintains regional strength through tailored solutions for Japanese farmers and niche applications like bee tick repellents. Beyond agrochemicals, Nihon Nohyaku diversifies into real estate and analytical services, though these remain ancillary to its core revenue streams.

Revenue Profitability And Efficiency

In FY2024, Nihon Nohyaku reported revenue of ¥103 billion, with net income of ¥4.8 billion, reflecting a modest net margin of approximately 4.6%. Operating cash flow was negative at ¥-344 million, likely due to working capital adjustments or timing disparities, while capital expenditures of ¥-1.6 billion suggest ongoing investments in production or R&D. The diluted EPS of ¥60.88 underscores stable but unspectacular earnings power.

Earnings Power And Capital Efficiency

The company’s earnings are supported by its agrochemical core, though the negative operating cash flow raises questions about short-term liquidity management. With a beta of 0.15, the business exhibits low volatility, typical of defensive agricultural sectors, but its capital efficiency metrics are muted, as seen in the modest net income relative to revenue.

Balance Sheet And Financial Health

Nihon Nohyaku holds ¥20.6 billion in cash against ¥39.7 billion in total debt, indicating a leveraged but manageable position. The debt-to-equity ratio is not explicitly provided, but the liquidity cushion appears adequate for near-term obligations. The balance sheet reflects a traditional agrochemical firm with moderate leverage and sufficient liquidity for cyclical downturns.

Growth Trends And Dividend Policy

Growth trends are steady rather than explosive, with the dividend payout of ¥22 per share suggesting a commitment to shareholder returns despite limited earnings growth. The company’s focus on niche markets like animal health and termite control may offer incremental growth, but broader agricultural demand cycles will likely dictate top-line performance.

Valuation And Market Expectations

At a market cap of ¥61.4 billion, the company trades at a P/E of approximately 12.9x, aligning with sector peers. The low beta implies market expectations of stability, but the valuation does not price in significant expansion, reflecting the company’s regional focus and moderate scale.

Strategic Advantages And Outlook

Nihon Nohyaku’s strengths lie in its long-standing market presence, diversified agrochemical portfolio, and Adeka Corporation’s backing. However, its outlook is tempered by competitive pressures and reliance on Japan’s agricultural sector. Strategic investments in R&D and international expansion could enhance growth, but execution risks remain.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount